Skip to Main Content

Author Details

Karen J Taylor
University of Edinburgh
1996
21
15
PMIDPaper TitleJournal TitlePublished Year
35144966Breast Cancer Index Is a Predictive Biomarker of Treatment Benefit and Outcome from Extended Tamoxifen Therapy: Final Analysis of the Trans-aTTom Study.Clin Cancer Res2022
36527133Correlative studies of the Breast Cancer Index (HOXB13/IL17BR) and ER, PR, AR, AR/ER ratio and Ki67 for prediction of extended endocrine therapy benefit: a Trans-aTTom study.Breast Cancer Res2022
26852132Downregulation of histone H2A and H2B pathways is associated with anthracycline sensitivity in breast cancer.Breast Cancer Res2016
25312014Molecular characterisation of isogenic taxane resistant cell lines identify novel drivers of drug resistance.BMC Cancer2014
23152120Authors' reply.J Pathol2013
21638049In situ detection of HER2:HER2 and HER2:HER3 protein-protein interactions demonstrates prognostic significance in early breast cancer.Breast Cancer Res Treat2012
22430898Proximity ligation assays for isoform-specific Akt activation in breast cancer identify activated Akt1 as a driver of progression.J Pathol2012
20074932WWOX tumour suppressor gene polymorphisms and ovarian cancer pathology and prognosis.Eur J Cancer2010
20700126In situ quantification of HER2-protein tyrosine kinase 6 (PTK6) protein-protein complexes in paraffin sections from breast cancer tissues.Br J Cancer2010
20569502Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer.Breast Cancer Res2010
19458077WWOX gene expression abolishes ovarian cancer tumorigenicity in vivo and decreases attachment to fibronectin via integrin alpha3.Cancer Res2009
18273838Homozygous deletions may be markers of nearby heterozygous mutations: The complex deletion at FRA16D in the HCT116 colon cancer cell line removes exons of WWOX.Genes Chromosomes Cancer2008
18790776AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies.Mol Cancer Ther2008
15870886WWOX mRNA expression profile in epithelial ovarian cancer supports the role of WWOX variant 1 as a tumour suppressor, although the role of variant 4 remains unclear.Int J Oncol2005
14695176Identification of clinically relevant genes on chromosome 11 in a functional model of ovarian cancer tumor suppression.Cancer Res2003
11572989WWOX: a candidate tumor suppressor gene involved in multiple tumor types.Proc Natl Acad Sci U S A2001
10749141A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D.Cancer Res2000
10077528Identification and characterization of a homozygous deletion found in ovarian ascites by representational difference analysis.Genome Res1999
10383136Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer.Cancer Res1999
8640783Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis.Cancer Res1996
21544406A statistical analysis of chromosome 11 and 17 loss of heterozygosity in epithelial ovarian cancer.Int J Oncol1996
  • 1 - 21 of 21

Recommended Authors

Joshy George
Peter MacCallum Cancer Centre
Career Start Year 2005
Number of shared co-authors 2
Yuelin J Zhu
National Cancer Institute, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Darran P O'Connor
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 1
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 0
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 3
Ingrid Hedenfalk
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 3
Mar??a J Garc??a
Spanish National Cancer Research Centre (CNIO)
Career Start Year 1996
Number of shared co-authors 2
William M Gallagher
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Career Start Year 1996
Number of shared co-authors 3
Ronald Simon
Institute of Pathology, University Medical Center Hamburg-Eppendorf
Career Start Year 1996
Number of shared co-authors 1
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Career Start Year 1995
Number of shared co-authors 6
David G Huntsman
University of British Columbia
Career Start Year 1994
Number of shared co-authors 4
Phillip Buckhaults
University of South Carolina
Career Start Year 1993
Number of shared co-authors 0
Simon A Gayther
Cedars-Sinai Medical Center
Career Start Year 1993
Number of shared co-authors 4
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 0
Yong-Jie Lu
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1993
Number of shared co-authors 2
Carlos Caldas
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 7
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 3
Eberhard Korsching
Institutet of Bioinformatics, University Hospital of Munster, University of Munster
Career Start Year 1990
Number of shared co-authors 1
John W M Martens
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 6
Jonathan R Pollack
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 0
Laura J Van't Veer
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 2
Olli Kallioniemi
Karolinska Institute
Career Start Year 1984
Number of shared co-authors 0
Vessela N Kristensen
Faculty of Clinical Medicine, University of Oslo
Career Start Year 1983
Number of shared co-authors 2
David D L Bowtell
Peter MacCallum Cancer Centre
Career Start Year 1983
Number of shared co-authors 2
Alan Ashworth
UCSF Helen Diller Family Comprehensive Cancer Center
Career Start Year 1982
Number of shared co-authors 3
Edison T Liu
USA The Jackson Laboratory Cancer Center
Career Start Year 1982
Number of shared co-authors 0
Irene L Andrulis
University of Toronto
Career Start Year 1977
Number of shared co-authors 5
Anna DeFazio
Westmead Hospital
Career Start Year 1972
Number of shared co-authors 2
Paul S Meltzer
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1970
Number of shared co-authors 0
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Career Start Year 1959
Number of shared co-authors 3

Collaborators

John M S Bartlett
University of Edinburgh
Co-authored papers 8
Melanie Spears
Ontario Institute for Cancer Research
Co-authored papers 6
Carrie A Cunningham
Massachusetts General Hospital
Co-authored papers 4
Elizabeth Mallon
Queen Elizabeth University Hospital
Co-authored papers 3
Dennis C Sgroi
Co-authored papers 2
Chris Twelves
Leeds Teaching Hospitals NHS Trust, University of Leeds
Co-authored papers 2
Linda Liao
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 2
Daniel Rea
Institute of Cancer and Genomic Sciences, The University of Birmingham
Co-authored papers 2
Nicola Lyttle
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 2
Cindy Q Yao
Ontario Institute for Cancer Research
Co-authored papers 2
Tammy Piper
University of Edinburgh
Co-authored papers 2
Alison F Munro
Institute of Genetics and Cancer, University of Edinburgh, Western General Hospital
Co-authored papers 1
Robert Brown
Ovarian Cancer Action Research Centre, Imperial College London
Co-authored papers 1
Irina Kalatskaya
EMD Serono Research & Development Institute, Inc. (an affiliate of Merck KGaA)
Co-authored papers 1
Jorge S Reis-Filho
Memorial Sloan-Kettering Cancer Center
Co-authored papers 1
Sylvia Richardson
Co-authored papers 1
Euan A Stronach
Imperial College London
Co-authored papers 1
Charlie E Massie
University of Cambridge
Co-authored papers 1
Alan Mackay
Co-authored papers 1
Maryou B Lambros
The Institute of Cancer Research
Co-authored papers 1
Marsela Braunstein
Princess Margaret Cancer Centre
Co-authored papers 1
Lincoln Stein
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 1
Richard Marcellus
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 1
Paul C Boutros
University of California los angeles
Co-authored papers 1
Nazleen C Lobo
Ontario Institute for Cancer Research, University Avenue
Co-authored papers 1
Paul M Krzyzanowski
Ontario Institute for Cancer Research
Co-authored papers 1
Release 1.2